Asymptomatic pancreatic cystic neoplasm: a cost-effectiveness analysis of different strategies of management

Gastrointestinal Endoscopy

Volumn 70, Issue 4, 2009, Pages

  Das, Ananya ^a   Ngamruengphong, Saowanee ^a   Nagendra, Shweta ^a   Chak, Amitabh ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

AGED; ARTICLE; ASPIRATION CYTOLOGY; CLINICAL DECISION MAKING; COST EFFECTIVENESS ANALYSIS; CYST FLUID; ENDOSCOPIC ECHOGRAPHY; HUMAN; INOPERABLE CANCER; MONTE CARLO METHOD; PANCREAS CANCER; PANCREAS CYST; PANCREATIC CYSTIC NEOPLASM; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS; SURGICAL APPROACH; SURGICAL RISK; WATCHFUL WAITING;

EID: 70349451686     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2009.02.013     Document Type: Article

References (56)

1. Kimura W., Nagai H., Kuroda A., et al. Analysis of small cystic lesions of the pancreas. Int J Pancreatol 18 (1995) 197-206
2. Brugge W.R. Approach to cystic pancreatic lesions. Gastrointest Endosc Clin N Am 15 (2005) 485-496
3. Fernandez-del Castillo C., and Warshaw A.L. Cystic tumors of the pancreas. Surg Clin of North Am 75 (1995) 1001-1016
4. Balcom J.H., Fernandez-del Castillo C., and Warshaw A.L. Cystic lesions in the pancreas: when to watch, when to resect. Curr Gastroenterol Rep 2 (2000) 152-158
5. Goh B.K., Tan Y.M., Chung Y.F., et al. Pancreatic cysts: a proposed management algorithm based on current evidence. Am J of Surg 193 (2007) 749-755
6. Brugge W.R., Lauwers G.Y., Sahani D., et al. Cystic neoplasms of the pancreas. N Engl J Med 351 (2004) 1218-1226
7. Brugge W.R., Lewandrowski K., Lee-Lewandrowski E., et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 126 (2004) 1330-1336
8. Gourgiotis S., Germanos S., and Ridolfini M.P. Presentation and management of pancreatic cystic neoplasms. J Clin Gastroenterol 41 (2007) 599-608
9. Sugiyama M., Izumisato Y., Abe N., et al. Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas. Br J Surg 90 (2003) 1244-1249
10. Rodriguez J.R., Salvia R., Crippa S., et al. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology 133 (2007) 72-79
11. Tanaka M., Chari S., Adsay V., et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6 (2006) 17-32
12. Sonnenberg F.A., and Beck J.R. Markov models in medical decision making: a practical guide. Med Decis Making 13 (1993) 322-338
13. Arias E. United States life tables, 2003. National vital statistic reports; vol. 54 no. 4 (2006), National Center for Health Statistics, Hyattsville (Md)
14. Weinstein M.C., Siegel J.E., Gold M.R., et al. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 276 (1996) 1253-1258
15. Johnson C.D., Stephens D.H., Charboneau J.W., et al. Cystic pancreatic tumors: CT and sonographic assessment. AJR Am J Roentgenol 151 (1988) 1133-1138
16. In: Adler M., and Ziglio E. (Eds). Gazing into the oracle: the Delphi method and its application to social policy and public health (1996), Jessica Kingsley Publishers, London (UK)
17. Owens W.D., Felts J.A., and Spitznagel Jr. E.L. ASA physical status classifications: a study of consistency of ratings. Anesthesiology 49 (1978) 239-243
18. Van der Waaji L.A., Van Dullemen H.M., and Porte R.J. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis. Gastrointest Endosc 62 (2005) 383-389
19. Khalid A., McGrath K.M., Zahid M., et al. The role of pancreatic cyst fluid molecular analysis in predicting cyst pathology. Clin Gastroenterol Hepatol 3 (2005) 967-973
20. Jacobson B.C., Baron T.H., Adler D.G., et al. American Society for Gastrointestinal Endoscopy. ASGE guideline: the role of endoscopy in the diagnosis and the management of cystic lesions and inflammatory fluid collections of the pancreas. Gastrointest Endosc 61 (2005) 363-370
21. Allen P.J., and Brennan M.F. The management of cystic lesions of the pancreas. Adv Surg 41 (2007) 211-228
22. Sarr M.G., Kendrick M.L., Nagomey D.M., et al. Cystic neoplasms of the pancreas: benign to malignant epithelial neoplasms. Surg Clin North Am 81 (2001) 497-509
23. Compagno J., and Oertel J.E. Mucinous cystic neoplasms of the pancreas with overt and latent malignancy (cystadenocarcinoma and cystadenoma): a clinicopathologic study of 41 cases. Am J Clin Pathol 69 (1978) 573-578
24. Warshaw A.L., Compton C.C., Lewandrowski K., et al. Cystic tumors of the pancreas: new clinical, radiologic, and pathologic observations in 67 patients. Ann Surg 212 (1990) 432-443
25. Zamboni G., Scarpa A., Bogina G., et al. Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surgical Path 23 (1999) 410-422
26. Reddy R.P., Smyrk T.C., Zapiach M., et al. Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer. Clin Gastroenterol Hepatol 2 (2004) 1026-1031
27. Kobari M., Egawa S., Shibuya K., et al. Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management. Arch Surg 134 (1999) 1131-1136
28. Terris B., Ponsot P., Paye F., et al. Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol 24 (2000) 1372-1377
29. Matsumoto T., Aramaki M., Yada K., et al. Optimal management of the branch duct type intraductal papillary mucinous neoplasms of the pancreas. J Clin Gastroenterol 36 (2003) 261-265
30. Sugiyama M., Izumisato Y., Abe N., et al. Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas. Br J Surg 90 (2003) 1244-1249
31. Lee C.J., Scheiman J., Anderson M.A., et al. Risk of malignancy in resected cystic tumors of the pancreas < or =3 cm in size: Is it safe to observe asymptomatic patients? A multi-institutional report. J Gastrointest Surg 12 (2008) 234-242
32. Handrich S.J., Hough D.M., Fletcher J.G., et al. The natural history of the incidentally discovered small simple pancreatic cyst: long term follow-up and clinical implications. AJR Am J Roentgenol 184 (2005) 20-23
33. Walsh R.M., Vogt D.P., Henderson J.M., et al. Natural history of indeterminate pancreatic cysts. Surgery 138 (2005) 665-670
34. Tanno S., Nakano Y., Nishikawa T., et al. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results. Gut 57 (2008) 339-343
35. Suzuki Y., Atomi Y., Sugiyama M., et al. Japanese multiinstitutional study of intraductal papillary mucinous tumor and mucinous cystic tumor. Pancreas 28 (2004) 241-246
36. Büchler M.W., Wagner M., Schmied B.M., et al. Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg 138 (2003) 1310-1314
37. Birkmeyer J.D., Stukel T.A., Siewers A.E., et al. Surgeon volume and operative mortality in the United States. N Engl J Med 349 (2003) 2117-2127
38. Rubenstein J.H., Scheiman J.M., and Anderson M.A. A clinical and economic evaluation of endoscopic ultrasound for patients at risk for familial pancreatic adenocarcinoma. Pancreatology 7 (2007) 514-525
39. Ries LAG, Eisner MP, Kosary CL, et al, editors. SEER Cancer Statistics Review, 1975-2002. Bethesda (Md): National Cancer Institute. Available at http://seer.cancer.gov/csr/1975_2002/. Accessed October 7, 2007.
40. Schniewind B., Bestmann B., Henne-Bruns D., et al. Quality of life after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head. Br J Surg 93 (2006) 1099-1107
41. Müller-Nordhorn J., Roll S., Böhmig M., et al. Health-related quality of life in patients with pancreatic cancer. Digestion 74 (2006) 118-125
42. Langenhoff B.S., Krabbe P.F., Wobbes T., et al. Quality of life as an outcome measure in surgical oncology. Br J Surg 88 (2001) 643-652
43. Porter G.A., Pisters P.W., Mansyur C., et al. Cost and utilization impact of a clinical pathway for patients undergoing pancreaticoduodenectomy. Ann Surg Oncol 7 (2000) 484-489
44. HCUPnet. Healthcare cost and utilization project. Rockville (Md): Agency for Healthcare Research and Quality. Available at http://www.ahrq.gov/HCUPnet/. Accessed October 4, 2007.
45. Proposed CY2005 hospital outpatient prospective payment system: addendum A. Available at: http://www.cms.hhs.gov/providers/hopps/fr2005.asp. Accessed October 4, 2007.
46. In: Gold M.R., Siegel J.E., and Russell L.B. (Eds). Cost-effectiveness in health and medicine (1996), Oxford University Press, New York (NY)
47. Doubilet P., Begg C.B., Weinstein M.C., et al. Probabilistic sensitivity analysis using Monte Carlo simulation: a practical approach. Med Decis Making 5 (1985) 157-177
48. Stinnett A.A., and Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making 18 Suppl (1998) S68-S80
49. Heitjan D.F. Fieller's method and net health benefit. Health Econ 9 (2000) 327-335
50. Allen P.J., D'Angelica M., Gonen M., et al. A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann Surg 244 (2006) 572-582
51. Khalid A., and Brugge W. ACG practice guidelines for the diagnosis and management of neoplastic pancreatic cysts. Am J Gastroenterol 102 (2007) 2339-2349
52. Lim S.J., Alasadi R., Wayne J.D., et al. Preoperative evaluation of pancreatic cystic lesions: cost-benefit analysis and proposed management algorithm. Surgery 138 (2005) 672-680
53. Liao T., and Velanovich V. Asymptomatic pancreatic cysts: a decision analysis approach to observation versus resection. Pancreas 35 (2007) 243-248
54. Wilentz R.E., Albores-Saavedra J., Zahurak M., et al. Pathologic examination accurately predicts prognosis in mucinous cystic neoplasms of the pancreas. Am J Surg Pathol 23 (1999) 1320-1327
55. Craig B.A., Black M.A., and Sendi P.P. Uncertainty in decision models analyzing cost-effectiveness. Med Decis Making 20 (2000) 135-137
56. Das A., Singh P., Sivak Jr. M.V., et al. Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis. Gastrointest Endosc 65 (2007) 960-968